Agilent Technologies Inc (A) Stock AnalysisAStock AnalysisAgilent Technologies Inc

Agilent Technologies, Inc. specializes in life sciences, diagnostics and applied markets, providing application-focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. Its segments include Life Sciences and Diagnostics Markets, Agilent CrossLab and Applied Markets. The Life Sciences and Diagnostics Markets segment provides contract development and manufacturing services for pharmaceutical customers as well as solutions that include reagents, instruments, software and consumables which enable customers in the clinical and life sciences research areas to interrogate samples at the cellular and molecular level. The Agilent CrossLab segment spans the entire lab with its services and consumables portfolio in addition to software and laboratory automation solutions, which are designed to improve customer outcomes and represent a range of offerings designed to serve customer needs across end-markets and applications. It operates in the Healthcare sector (LABORATORY ANALYTICAL INSTRUMENTS industry).

Agilent Technologies is a good buy right now due to its recent strong financial performance, including a 7.3% core revenue growth in Q3 FY2026, and a current price of $153.84, which is below the average analyst price target of $180. The stock has a forward P/E ratio of 23.26, suggesting it is reasonably valued for future growth. The main risk is the recent 5-day price change of -3.25%, indicating short-term volatility.